Evidence map›Paper›PMID 39377824›Full record

ArticleJournal of medical systems2024

Preventing Overrides of Severe Drug Allergy Alerts Initiative: an Implemented System Upgrade.

Laila Carolina Abu Esba, Samar Al Moaiseib, Norah Saud BinSabbar, Ghada Hussain Salamah Al Mardawi, Mufareh Alkatheri, Saleh Al Dekhail

Abstract read
In one paragraph

Article in Journal of medical systems, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Laila Carolina Abu EsbaKing Abdulaziz Medical City, Ministry of National Guard, Health Affairs, Joint Appointment Lecturer of Pharmacy Practice, King Saud Bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Centre, PO Box 22490, Riyadh, 11426, Kingdom of Saudi Arabia. abuesbala@ngha.med.sa.
Samar Al MoaiseibCorporate Clinical Information Management System, Information Technology, Riyadh, Saudi Arabia.
Norah Saud BinSabbarSaudi Medication Safety Center, MNGHA, P.O.Box 22490, 11426, Mail Code 2339, Riyadh, Saudi Arabia.
Ghada Hussain Salamah Al MardawiKing Abdulaziz Medical City, Ministry of National Guard, Health Affairs, King Abdullah International Medical Research Centre, PO Box 22490, Riyadh, 11426, Kingdom of Saudi Arabia.
Mufareh AlkatheriDepartment of Quality Improvement, King Abdulaziz Medical City, King Abdulaziz International Medical Research, Center, Ministry of National Guard - Health Affairs, Riyadh, Saudi Arabia.
Saleh Al DekhailKing Abdulaziz Medical City, Ministry of NG-HA, KSAU-HS, P.O. Box 22490, Riyadh, 11426, Kingdom of Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Administering medications to patients with documented drug hypersensitivity reactions (DHR) poses a significant risk for adverse events, ranging from mild reactions to life-threatening incidents. Electronic healthcare systems have revolutionized the modern clinical decision-making process, with built in warnings. However, as these alerts become a routine part of healthcare provider's workflow, alert fatigue becomes a challenge. This study was conducted within the Ministry of National Guard Health Affairs (MNGHA), a government healthcare system in Saudi Arabia. A taskforce of experts was formed to develop an electronic path that would prevent unintentional overrides of severe drug allergy alerts. The system underwent rigorous testing, and monitoring parameters were established. We outline the implementation of a system upgrade designed to trigger an alternative interruption in the computerized physician order entry (CPOE) process, distinct from the regular allergy pop-up alerts. The alternate path is activated upon a CPOE with a drug-to-drug match and a documented severe drug allergy symptom, necessitating co-signature form another prescriber before proceeding. The adopted upgrade is a proactive approach to enhance medication safety in electronic healthcare systems, ensuring that serious allergy-related warnings are not overridden, ultimately enhancing patient safety. Further monitoring will confirm the safety and effectiveness of this measure. This study provides a model for institutions seeking to prevent allergy-related harm within their patient population.

Indexed as

Drug HypersensitivityMedical Order Entry SystemsAlert Fatigue, Health PersonnelDecision Support Systems, ClinicalHumansMedication ErrorsSaudi ArabiaAlert FatigueAllergy AlertCPOEDrug-Allergy ReactionDrug Hypersensitivity ReactionsOverridePatient Safety

Identifiers

PMID39377824
PMCPMC11461780

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.